Xinyang Liu*1, Zhichao Wang*1, Zongwei Chen†1, Longzi Liu*, Lijie Ma*, Liangqing Dong*, Zhao Zhang*, Shu Zhang*, Liuxiao Yang*, Jieyi Shi*, Jia Fan*‡, Xiaoying Wang*, Qiang Gao*‡
Oncology Research, Vol.26, No.2, pp. 231-239, 2018, DOI:10.3727/096504017X15051752095738
Abstract Hepatocellular carcinoma (HCC) is a worldwide health threat with increasing incidence and a high mortality rate. Most HCC patients are diagnosed at an advanced stage and are unable to undergo potential curative
surgery. Transcatheter arterial chemoembolization (TACE) and transcatheter arterial chemotherapy infusion
(TACI) are two of the main palliative treatments for advanced HCC patients. The clinical efficacy and safety
of TACE and TACI are controversial. For this reason, we conducted a systematic review and meta-analysis to
summarize the current evidence. We searched for randomized controlled trials (RCTs) and cohort studies that
compared the clinical outcomes… More >
Login
Register
